ARM Holdings: Bernstein downgrades to underperform. GlaxoSmithKline: Liberum ups view to hold from sell. HSBC initiates coverage at buy with 1,700p target. AztraZeneca: HSBC initiates coverage at hold with 4,640p target. Qinetiq: UBS downgrades to sell from neutral. Meggitt: UBS raises view to ne
Read moreRBC Capital Markets downgraded BP to' sector perform' from 'outperform' and kept the price target at 500p, following the stock's significant outperformance versus its closest peer Royal Dutch Shell. "We continue to see potential upside to BP's cost reduction potential, but feel the risk reward oppor
Read moreMorgan Stanley downgraded Kingfisher to 'underweight' from 'equalweight', but raised the price target to 310p from 300p. The bank noted that since it upgraded the stock in December, Kingfisher has exited China at a price below asset value, seen its proposed acquisition of Mr Bricolage fall through a
Read moreKingfisher said on Thursday that it has appointed Michael Loeve as chief executive officer of B&Q UK & Ireland. Loeve, who will join the business in September, is currently group retail director at Coop Danmark, where he is responsible for five retail formats, including Irma, Kvickly and Fakta. Kin
Read more